相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Peptide receptor imaging in neuroendocrine tumors: comparison between diagnostic scintigraphy and post-therapy whole-body scan
Fabio Minutoli et al.
ANNALS OF NUCLEAR MEDICINE (2013)
mTORC1 Inhibitors Suppress Meningioma Growth in Mouse Models
Doreen Pachow et al.
CLINICAL CANCER RESEARCH (2013)
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
John J. Zaknun et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Integration of functional neuroimaging in CyberKnife radiosurgery: feasibility and dosimetric results
Alfredo Conti et al.
NEUROSURGICAL FOCUS (2013)
Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma
Marc C. Chamberlain
JOURNAL OF NEURO-ONCOLOGY (2012)
Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series
Emil Lou et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Atypical and anaplastic meningiomas treated with bevacizumab
Lakshmi Nayak et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment
S. Baldari et al.
Pituitary (2012)
Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma
Michael C. Kreissl et al.
RADIATION ONCOLOGY (2012)
Estimation of absorbed dose to the kidneys in patients after treatment with Lu-177-octreotate: comparison between methods based on planar scintigraphy
Maria Larsson et al.
EJNMMI RESEARCH (2012)
Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes
A. Durand et al.
CLINICAL NEUROPATHOLOGY (2011)
Meningioma: review of the literature with emphasis on the approach to radiotherapy
Gustavo Nader Marta et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
Anna Imhof et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series
Marc C. Chamberlain et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma
Derek R. Johnson et al.
NEURO-ONCOLOGY (2011)
Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report
Amir Sabet et al.
RADIATION ONCOLOGY (2011)
Bevacizumab-induced regression of anaplastic meningioma
M. J. A. Puchner et al.
ANNALS OF ONCOLOGY (2010)
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging
Emilio Bombardieri et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors
Dik J. Kwekkeboom et al.
SEMINARS IN NUCLEAR MEDICINE (2010)
Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma
Mirco Bartolomei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs
Dik J. Kwekkeboom et al.
NEUROENDOCRINOLOGY (2009)
Interferon-α for Recurrent World Health Organization Grade 1 Intracranial Meningiomas
Marc C. Chamberlain et al.
CANCER (2008)
Safety and efficacy of radionuclide therapy with high-activity In-111 pentetreotide in patients with progressive neuroendocrine tumors
Ebrahim S. Delpassand et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2008)
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE:: the role of associated risk factors
Lisa Bodei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Recurrent meningioma - Salvage therapy with long-acting somatostatin analogue
Marc C. Chamberlain et al.
NEUROLOGY (2007)
Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: Results of a pilot study
BM Hahn et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3] octreotate in patients with endocrine gastroenteropancreatic tumors
DJ Kwekkeboom et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Non-resectable slow-growing meningiomas treated by hydroxyurea
D Loven et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity
S Arena et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Gamma knife radiosurgery of imaging-diagnosed intracranial meningioma
JC Flickinger et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities
WAP Breeman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide:: The Rotterdam experience
R Valkema et al.
SEMINARS IN NUCLEAR MEDICINE (2002)
Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings
M de Jong et al.
SEMINARS IN NUCLEAR MEDICINE (2002)
Receptor-mediated radiotherapy with 90Y-DOTA-DPhe1-Tyr3-octreotide:: The experience of the European Institute of Oncology Group
M Chinol et al.
SEMINARS IN NUCLEAR MEDICINE (2002)
Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives
WAP Breeman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
[177Lu-DOTA0,Tyr3]octreotate:: comparison with [111In-DTPA0]octreotide in patients
DJ Kwekkeboom et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
Hydroxyurea chemotherapy for unresectable or residual meningioma
HB Newton et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
分享论文
